Georges E. Janssens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Georges E. Janssens has a total of 290 co-authors. Here are the top co-authors by number of shared publications:
- Riekelt H. Houtkooper
Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands
22 shared publications Bauke V. Schomakers
Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
14 shared publications- Michel van Weeghel
Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands
12 shared publications Riekelt H. Houtkooper
Laboratory Genetic Metabolic Diseases, Amsterdam UMC — Location AMC, University of Amsterdam, Amsterdam, the Netherlands
10 shared publicationsRashmi Kamble
Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands
9 shared publications- Frederic Maxime Vaz
Laboratory Genetic Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands
7 shared publications
Latest Publications
- 6 October 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (10) , 2074-2091
Longer lipids mark aging and constrain lifespan
- 6 October 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (10) , 2074-2091
Longer lipids mark aging and constrain lifespan
- 3 July 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (7) , 1482-1500
Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle
Exercise is fundamental to healthy aging, yet how it mitigates age-related molecular changes and how fitness level shapes exercise responses remain unclear. To address these questions, we performed transcriptomics, lipidomics and metabolomics on skeletal muscle of young and older adults with differing physical function, both before and after an acute bout of submaximal exercise. At baseline, older adults exhibited reduced expression of genes associated with cellular respiration and energy metabolism compared to young adults with comparable activity levels. Here we found that 50% of these age-related differences were absent in trained older adults, resulting in profiles resembling those of young adults. Although all participants displayed transcriptional immune and stress responses upon acute exercise, the magnitude of these responses in older adults was positively correlated with their physical fitness. Integrated multiomic analyses further revealed links among mitochondrial respiration, lipid metabolism, stress responses and NAD+ biology. These findings demonstrate that sustained physical training transforms age-related molecular profiles and provide a molecular atlas for study of fitness-dependent aging mechanisms.
- 3 July 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (7) , 1482-1500
Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle
Exercise is fundamental to healthy aging, yet how it mitigates age-related molecular changes and how fitness level shapes exercise responses remain unclear. To address these questions, we performed transcriptomics, lipidomics and metabolomics on skeletal muscle of young and older adults with differing physical function, both before and after an acute bout of submaximal exercise. At baseline, older adults exhibited reduced expression of genes associated with cellular respiration and energy metabolism compared to young adults with comparable activity levels. Here we found that 50% of these age-related differences were absent in trained older adults, resulting in profiles resembling those of young adults. Although all participants displayed transcriptional immune and stress responses upon acute exercise, the magnitude of these responses in older adults was positively correlated with their physical fitness. Integrated multiomic analyses further revealed links among mitochondrial respiration, lipid metabolism, stress responses and NAD+ biology. These findings demonstrate that sustained physical training transforms age-related molecular profiles and provide a molecular atlas for study of fitness-dependent aging mechanisms.
- Top Cited Papers
- 14 May 2026
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (6) , 1282-1290
Human whole-blood NAD+ levels do not vary with age or lifestyle interventions
Nicotinamide adenine dinucleotide (NAD+) levels in blood and tissues are widely proposed to decline with age, yet evidence in human blood is inconsistent. Using a rigorously validated ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry system that accounts for real-world analytical variability, we quantify NAD+ across seven independent human cohorts. We find that whole-blood NAD+ levels remain remarkably stable with age and across lifestyle interventions, but change in response to nicotinamide riboside supplementation, as expected. Our results challenge the utility of blood NAD+ levels as a biomarker of ageing or lifestyle factors.
- 14 May 2026
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (6) , 1282-1290
Top Cited PapersHuman whole-blood NAD+ levels do not vary with age or lifestyle interventions
Nicotinamide adenine dinucleotide (NAD+) levels in blood and tissues are widely proposed to decline with age, yet evidence in human blood is inconsistent. Using a rigorously validated ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry system that accounts for real-world analytical variability, we quantify NAD+ across seven independent human cohorts. We find that whole-blood NAD+ levels remain remarkably stable with age and across lifestyle interventions, but change in response to nicotinamide riboside supplementation, as expected. Our results challenge the utility of blood NAD+ levels as a biomarker of ageing or lifestyle factors.
- Open Access
- 17 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71582
Reduced Versus Oxidized NAD + Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes
Nicotinamide adenine dinucleotide (NAD + ) is a vital molecule, serving as a redox cofactor and the limiting substrate for numerous enzymes. NAD + decline is a key feature of aging, while supplementation with NAD + precursors can efficiently counteract aging traits and prevent age‐associated conditions in preclinical models. However, clinical translation remains challenging, likely due to the limited NAD + boosting capacity of classical precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). This has brought attention to their reduced forms, reduced NMN (NMNH) and reduced NR (NRH), which are more potent NAD + boosters but remain poorly characterized. Here, we performed a comprehensive comparative analysis using RNA sequencing, proteomics, and metabolomics on cultured murine hepatocytes treated with NMN, NMNH, NR, or NRH. Global metabolic profiling revealed that NRH and NMNH induced substantially broader metabolic alterations than NR and NMN, with NRH uniquely suppressing metabolites involved in energy metabolism. The pronounced metabolic effects were reflected at a transcriptional level, with reduced precursors triggering a significantly higher number of differentially expressed genes than oxidized ones. Shared differentially expressed genes between NMNH and NRH revealed upregulation of stress‐related glutathione‐ S ‐transferases ( Gsts ) which furthermore were reflected in our proteomic profiling. However, the upregulation of Gsts did not cause a depletion of glutathione or oxiglutathione, suggesting a pseudo‐stress response to reduced NAD + precursors. Together, our data demonstrate that reduced NAD + precursors are unique and distinct from the market‐available NAD + precursors NR and NMN, not only as more potent NAD + boosters, but also as compounds influencing a broader range of cellular processes.
- 17 February 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (4) , e71582
Open AccessReduced Versus Oxidized NAD + Precursors Drive Distinct Transcriptomic, Proteomic, and Metabolic Profiles in Hepatocytes
Nicotinamide adenine dinucleotide (NAD + ) is a vital molecule, serving as a redox cofactor and the limiting substrate for numerous enzymes. NAD + decline is a key feature of aging, while supplementation with NAD + precursors can efficiently counteract aging traits and prevent age‐associated conditions in preclinical models. However, clinical translation remains challenging, likely due to the limited NAD + boosting capacity of classical precursors, such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). This has brought attention to their reduced forms, reduced NMN (NMNH) and reduced NR (NRH), which are more potent NAD + boosters but remain poorly characterized. Here, we performed a comprehensive comparative analysis using RNA sequencing, proteomics, and metabolomics on cultured murine hepatocytes treated with NMN, NMNH, NR, or NRH. Global metabolic profiling revealed that NRH and NMNH induced substantially broader metabolic alterations than NR and NMN, with NRH uniquely suppressing metabolites involved in energy metabolism. The pronounced metabolic effects were reflected at a transcriptional level, with reduced precursors triggering a significantly higher number of differentially expressed genes than oxidized ones. Shared differentially expressed genes between NMNH and NRH revealed upregulation of stress‐related glutathione‐ S ‐transferases ( Gsts ) which furthermore were reflected in our proteomic profiling. However, the upregulation of Gsts did not cause a depletion of glutathione or oxiglutathione, suggesting a pseudo‐stress response to reduced NAD + precursors. Together, our data demonstrate that reduced NAD + precursors are unique and distinct from the market‐available NAD + precursors NR and NMN, not only as more potent NAD + boosters, but also as compounds influencing a broader range of cellular processes.
- 15 November 2025
- Published by Springer Nature in GeroScience
- Vol. 48 (2) , 1553-1570
A scalable step count-based predictor of biological age: development and validation of MoveIt! Age in community-dwelling adults and geriatric rehabilitation inpatients
Measuring biological age typically requires invasive and costly procedures. To address this, the MoveIt! Age Score was developed: a simple, scalable, and interpretable aging clock that predicts biological age using only wearable-derived steps data. MoveIt! Age was trained on steps data from the United States National Health and Nutrition Examination Survey (NHANES), using chronological age, maximum step count, and step count variability to predict PhenoAge, a blood biochemistry biological age score. MoveIt! Age performance was evaluated in two independent cohorts: Mitochondria and Muscle Health in Elderly (MitoHealth; N = 55; healthy young adults or older adults from the Netherlands) and Restoring Health of Acutely Unwell Adults (RESORT; N = 145; geriatric rehabilitation inpatients from Australia). In RESORT, MoveIt! Age was assessed and compared to SenoClock-BloodAge and PhenoAge (hematological aging clocks). Delta age was the predicted biological age minus chronological age. In the NHANES testing dataset, MoveIt! Age demonstrated high predictive accuracy of chronological age (r = 0.97, RMSE = 5.4 years) and was more significantly associated with mortality than PhenoAge. In MitoHealth, delta MoveIt! Age showed differences between young adults and older adults who were normal, healthy, or health-impaired, with MoveIt! Age more significantly associated with muscle NAD+ levels (r = −0.37, p = 0.023) than chronological age (p = 0.416). Delta MoveIt! Age associated more strongly than other clocks with physical function outcomes, including frailty, handgrip strength, and functional performance. These findings support MoveIt! Age as a practical tool to gain insights into biological age in both clinical and community settings.
- 15 November 2025
- Published by Springer Nature in GeroScience
- Vol. 48 (2) , 1553-1570
A scalable step count-based predictor of biological age: development and validation of MoveIt! Age in community-dwelling adults and geriatric rehabilitation inpatients
Measuring biological age typically requires invasive and costly procedures. To address this, the MoveIt! Age Score was developed: a simple, scalable, and interpretable aging clock that predicts biological age using only wearable-derived steps data. MoveIt! Age was trained on steps data from the United States National Health and Nutrition Examination Survey (NHANES), using chronological age, maximum step count, and step count variability to predict PhenoAge, a blood biochemistry biological age score. MoveIt! Age performance was evaluated in two independent cohorts: Mitochondria and Muscle Health in Elderly (MitoHealth; N = 55; healthy young adults or older adults from the Netherlands) and Restoring Health of Acutely Unwell Adults (RESORT; N = 145; geriatric rehabilitation inpatients from Australia). In RESORT, MoveIt! Age was assessed and compared to SenoClock-BloodAge and PhenoAge (hematological aging clocks). Delta age was the predicted biological age minus chronological age. In the NHANES testing dataset, MoveIt! Age demonstrated high predictive accuracy of chronological age (r = 0.97, RMSE = 5.4 years) and was more significantly associated with mortality than PhenoAge. In MitoHealth, delta MoveIt! Age showed differences between young adults and older adults who were normal, healthy, or health-impaired, with MoveIt! Age more significantly associated with muscle NAD+ levels (r = −0.37, p = 0.023) than chronological age (p = 0.416). Delta MoveIt! Age associated more strongly than other clocks with physical function outcomes, including frailty, handgrip strength, and functional performance. These findings support MoveIt! Age as a practical tool to gain insights into biological age in both clinical and community settings.
- 9 September 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (9) , 1704-1731
Emerging strategies, applications and challenges of targeting NAD+ in the clinic
Beyond their classical functions as redox cofactors, recent fundamental and clinical research has expanded our understanding of the diverse roles of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) in signaling pathways, epigenetic regulation and energy homeostasis. Moreover, NAD and NADP influence numerous diseases as well as the processes of aging, and are emerging as targets for clinical intervention. Here, we summarize safety, bioavailability and efficacy data from NAD+-related clinical trials, focusing on aging and neurodegenerative diseases. We discuss the established NAD+ precursors nicotinic acid and nicotinamide, newer compounds such as nicotinamide riboside and nicotinamide mononucleotide, and emerging precursors. We also discuss technological advances including in industrial-scale production and real-time detection, which are facilitating NAD+ research and clinical translation. Finally, we emphasize the need for further large-scale studies to determine optimal dose, administration routes and frequency, as well as long-term safety and interindividual variability in response.
- 9 September 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (9) , 1704-1731
Emerging strategies, applications and challenges of targeting NAD+ in the clinic
Beyond their classical functions as redox cofactors, recent fundamental and clinical research has expanded our understanding of the diverse roles of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) in signaling pathways, epigenetic regulation and energy homeostasis. Moreover, NAD and NADP influence numerous diseases as well as the processes of aging, and are emerging as targets for clinical intervention. Here, we summarize safety, bioavailability and efficacy data from NAD+-related clinical trials, focusing on aging and neurodegenerative diseases. We discuss the established NAD+ precursors nicotinic acid and nicotinamide, newer compounds such as nicotinamide riboside and nicotinamide mononucleotide, and emerging precursors. We also discuss technological advances including in industrial-scale production and real-time detection, which are facilitating NAD+ research and clinical translation. Finally, we emphasize the need for further large-scale studies to determine optimal dose, administration routes and frequency, as well as long-term safety and interindividual variability in response.
- Open Access
- 29 July 2025
- Published by Springer Nature in Clinical Epigenetics
- Vol. 17 (1) , 133
Nutritional associations with decelerated epigenetic aging: vegan diet in a Dutch population
The 2021 Aging Report of the European Union projected significant increases in healthcare costs, with some member states expecting up to a 60% rise over the next 50 years, primarily due to an aging population and related diseases. Interventions targeting aging have been proposed to reduce this burden by extending healthspan. Recent evidence suggests that vegan diets may slow the aging process. Using data from the Netherlands Twin Register (n = 22,124), dietary habits of meat eaters (n = 21,614), pescetarians (n = 294), vegetarians (n = 194), and vegans (n = 22) were examined, which were collected in a 2014–2016 survey period. Health parameters such as BMI, waist circumference, and insulin sensitivity showed improved health with more plant-based diets, though results were not adjusted for confounders. Epigenetic age was assessed using the Hannum, Horvath, PhenoAge, GrimAge, and Dunedin Pace of Aging clocks for 3049 participants with DNA methylation (DNAme) data from a 2004–2011 sample collection period and were compared to calendar age from the time of blood draw. Although discordant twin pairs with and without vegan diets (n = 3) were too few for statistical significance, their results suggested a potential benefit of veganism. In the subpopulation with complete data on DNA methylation, dietary habits, and covariates (n = 1198), veganism was significantly associated with lower epigenetic aging scores on the Hannum and Horvath clocks, even after adjusting for confounders (age, sex, smoking, education, physical activity, BMI, and alcohol use). Analysis of individual covariates in the model found that higher education, physical activity, being female, and non-smoking were associated with reduced epigenetic age, while higher BMI was linked to increased epigenetic age; however, since these parameters were used with the primary purpose of accounting for confounders, caution should be used in interpreting these results. Finally, dietary analysis showed that abstaining from pork was associated with lower biological ages (Dunedin Pace of Aging), whereas abstaining from poultry was linked to higher biological ages (PhenoAge, Dunedin Pace of Aging). Although with a small sample size and a large time gap between nutritional survey collection and blood collection for participant’s epigenetic ages, these findings suggest that dietary choices, particularly plant-based diets, may influence epigenetic aging. The results highlight the potential of veganism to reduce epigenetic age and underscore the importance of further research to clarify the relationship between diet and aging. Larger cohorts and clinical trials would be necessary to gain more certainty on our initial findings. The online version contains supplementary material available at 10.1186/s13148-025-01934-9.
- 29 July 2025
- Published by Springer Nature in Clinical Epigenetics
- Vol. 17 (1) , 133
Open AccessNutritional associations with decelerated epigenetic aging: vegan diet in a Dutch population
The 2021 Aging Report of the European Union projected significant increases in healthcare costs, with some member states expecting up to a 60% rise over the next 50 years, primarily due to an aging population and related diseases. Interventions targeting aging have been proposed to reduce this burden by extending healthspan. Recent evidence suggests that vegan diets may slow the aging process. Using data from the Netherlands Twin Register (n = 22,124), dietary habits of meat eaters (n = 21,614), pescetarians (n = 294), vegetarians (n = 194), and vegans (n = 22) were examined, which were collected in a 2014–2016 survey period. Health parameters such as BMI, waist circumference, and insulin sensitivity showed improved health with more plant-based diets, though results were not adjusted for confounders. Epigenetic age was assessed using the Hannum, Horvath, PhenoAge, GrimAge, and Dunedin Pace of Aging clocks for 3049 participants with DNA methylation (DNAme) data from a 2004–2011 sample collection period and were compared to calendar age from the time of blood draw. Although discordant twin pairs with and without vegan diets (n = 3) were too few for statistical significance, their results suggested a potential benefit of veganism. In the subpopulation with complete data on DNA methylation, dietary habits, and covariates (n = 1198), veganism was significantly associated with lower epigenetic aging scores on the Hannum and Horvath clocks, even after adjusting for confounders (age, sex, smoking, education, physical activity, BMI, and alcohol use). Analysis of individual covariates in the model found that higher education, physical activity, being female, and non-smoking were associated with reduced epigenetic age, while higher BMI was linked to increased epigenetic age; however, since these parameters were used with the primary purpose of accounting for confounders, caution should be used in interpreting these results. Finally, dietary analysis showed that abstaining from pork was associated with lower biological ages (Dunedin Pace of Aging), whereas abstaining from poultry was linked to higher biological ages (PhenoAge, Dunedin Pace of Aging). Although with a small sample size and a large time gap between nutritional survey collection and blood collection for participant’s epigenetic ages, these findings suggest that dietary choices, particularly plant-based diets, may influence epigenetic aging. The results highlight the potential of veganism to reduce epigenetic age and underscore the importance of further research to clarify the relationship between diet and aging. Larger cohorts and clinical trials would be necessary to gain more certainty on our initial findings. The online version contains supplementary material available at 10.1186/s13148-025-01934-9.
- Open Access
Targeting phospholipase PLAG-15 promotes healthy aging in C. elegans via lysosomal-related genes
- Open Access
- 18 March 2025
- Published by Springer Nature in Research Square
Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle
Exercise is fundamental to healthy aging, yet the degree to which it mitigates age-related molecular changes and how varying physical fitness levels influence the molecular response to exercise with age remain unclear. To address this, we performed transcriptomics, lipidomics, and metabolomics on skeletal muscle of young and older adults with differing physical function, both before and after an acute bout of sub-maximal exercise. At baseline, older adults exhibited reduced expression of genes associated with cellular respiration and energy metabolism compared to young adults with comparable activity levels. Remarkably, in trained older adults, 50% of these age-related differences were absent, resulting in transcriptomic profiles for cellular respiration that closely aligned with those of young adults. Following acute exercise, trained older adults demonstrated molecular responses that more closely resembled those of younger individuals. While all participants displayed transcriptional immune and stress responses upon acute exercise, the magnitude of these responses in older adults correlated positively with their physical fitness. These findings underscore the capacity of sustained physical training to transform age-related molecular profiles, highlight a positive link between physical fitness level and exercise-induced inflammation in older adults, and provide a multi-omic molecular atlas for examining aging and fitness regulatory networks.
- 18 March 2025
- Published by Springer Nature in Research Square
Open AccessDelayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle
Exercise is fundamental to healthy aging, yet the degree to which it mitigates age-related molecular changes and how varying physical fitness levels influence the molecular response to exercise with age remain unclear. To address this, we performed transcriptomics, lipidomics, and metabolomics on skeletal muscle of young and older adults with differing physical function, both before and after an acute bout of sub-maximal exercise. At baseline, older adults exhibited reduced expression of genes associated with cellular respiration and energy metabolism compared to young adults with comparable activity levels. Remarkably, in trained older adults, 50% of these age-related differences were absent, resulting in transcriptomic profiles for cellular respiration that closely aligned with those of young adults. Following acute exercise, trained older adults demonstrated molecular responses that more closely resembled those of younger individuals. While all participants displayed transcriptional immune and stress responses upon acute exercise, the magnitude of these responses in older adults correlated positively with their physical fitness. These findings underscore the capacity of sustained physical training to transform age-related molecular profiles, highlight a positive link between physical fitness level and exercise-induced inflammation in older adults, and provide a multi-omic molecular atlas for examining aging and fitness regulatory networks.
- Open Access
- 14 March 2025
- Published by Springer Nature in GeroScience
- Vol. 47 (3) , 5185-5204
Topoisomerase inhibitor amonafide enhances defense responses to promote longevity in C. elegans
Aging is a major risk factor for disease, and developing effective pharmaceutical interventions to improve healthspan and promote longevity has become a high priority for society. One of the molecular pathways related to longevity in various model organisms revolves around lowering AKT1 levels. This prompted our in silico drug screen for small molecules capable of mimicking the transcriptional effects of AKT1 knockdown. We found topoisomerase inhibitors as a top candidate longevity-drug class. Evaluating multiple compounds from this class in C. elegans revealed that the topoisomerase inhibitor amonafide has the greatest benefit on healthspan and lifespan. Intriguingly, the longevity effect of amonafide was not solely dependent on DAF-16/FOXO, the canonical pathway for lifespan extension via AKT1 inhibition. We performed RNA-seq on amonafide-treated worms and revealed a more youthful transcriptional signature, including the activation of diverse molecular and cellular defense pathways. We found the mitochondrial unfolded protein response (UPRmt) regulator afts-1 to be crucial for both improved healthspan and extended lifespan upon amonafide treatment. Moreover, healthspan was partially dependent on the immune response transcription factor zip-2 and the integrated stress response transcription factor atf-4. We further examined the potential of amonafide in age-related disease. Treating a C. elegans model for Parkinson’s disease with amonafide improved mobility. In conclusion, we identified amonafide as a novel geroprotector, which activates mitochondrial-, pathogen-, and xenobiotic-associated defense responses that—though more studies are needed—may serve as a candidate for Parkinson’s disease therapy.
- 14 March 2025
- Published by Springer Nature in GeroScience
- Vol. 47 (3) , 5185-5204
Open AccessTopoisomerase inhibitor amonafide enhances defense responses to promote longevity in C. elegans
Aging is a major risk factor for disease, and developing effective pharmaceutical interventions to improve healthspan and promote longevity has become a high priority for society. One of the molecular pathways related to longevity in various model organisms revolves around lowering AKT1 levels. This prompted our in silico drug screen for small molecules capable of mimicking the transcriptional effects of AKT1 knockdown. We found topoisomerase inhibitors as a top candidate longevity-drug class. Evaluating multiple compounds from this class in C. elegans revealed that the topoisomerase inhibitor amonafide has the greatest benefit on healthspan and lifespan. Intriguingly, the longevity effect of amonafide was not solely dependent on DAF-16/FOXO, the canonical pathway for lifespan extension via AKT1 inhibition. We performed RNA-seq on amonafide-treated worms and revealed a more youthful transcriptional signature, including the activation of diverse molecular and cellular defense pathways. We found the mitochondrial unfolded protein response (UPRmt) regulator afts-1 to be crucial for both improved healthspan and extended lifespan upon amonafide treatment. Moreover, healthspan was partially dependent on the immune response transcription factor zip-2 and the integrated stress response transcription factor atf-4. We further examined the potential of amonafide in age-related disease. Treating a C. elegans model for Parkinson’s disease with amonafide improved mobility. In conclusion, we identified amonafide as a novel geroprotector, which activates mitochondrial-, pathogen-, and xenobiotic-associated defense responses that—though more studies are needed—may serve as a candidate for Parkinson’s disease therapy.